438 related articles for article (PubMed ID: 32854584)
1. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
[TBL] [Abstract][Full Text] [Related]
3. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
4. In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.
Papa L; Mittal MK; Ramirez J; Ramia M; Kirby S; Silvestri S; Giordano P; Weber K; Braga CF; Tan CN; Ameli NJ; Lopez M; Zonfrillo M
J Neurotrauma; 2016 Jan; 33(1):58-64. PubMed ID: 25752485
[TBL] [Abstract][Full Text] [Related]
5. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
[TBL] [Abstract][Full Text] [Related]
7. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study.
Yue JK; Yuh EL; Korley FK; Winkler EA; Sun X; Puffer RC; Deng H; Choy W; Chandra A; Taylor SR; Ferguson AR; Huie JR; Rabinowitz M; Puccio AM; Mukherjee P; Vassar MJ; Wang KKW; Diaz-Arrastia R; Okonkwo DO; Jain S; Manley GT;
Lancet Neurol; 2019 Oct; 18(10):953-961. PubMed ID: 31451409
[TBL] [Abstract][Full Text] [Related]
9. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
10. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
11. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
[TBL] [Abstract][Full Text] [Related]
12. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
[TBL] [Abstract][Full Text] [Related]
13. Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma.
Papa L; Zonfrillo MR; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez M; Mittal MK
Acad Emerg Med; 2015 Nov; 22(11):1274-82. PubMed ID: 26469937
[TBL] [Abstract][Full Text] [Related]
14. GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.
Papa L; Silvestri S; Brophy GM; Giordano P; Falk JL; Braga CF; Tan CN; Ameli NJ; Demery JA; Dixit NK; Mendes ME; Hayes RL; Wang KK; Robertson CS
J Neurotrauma; 2014 Nov; 31(22):1815-22. PubMed ID: 24903744
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.
Posti JP; Takala RSK; Lagerstedt L; Dickens AM; Hossain I; Mohammadian M; Ala-Seppälä H; Frantzén J; van Gils M; Hutchinson PJ; Katila AJ; Maanpää HR; Menon DK; Newcombe VF; Tallus J; Hrusovsky K; Wilson DH; Gill J; Sanchez JC; Tenovuo O; Zetterberg H; Blennow K
J Neurotrauma; 2019 Jul; 36(14):2178-2189. PubMed ID: 30760178
[TBL] [Abstract][Full Text] [Related]
16. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
[TBL] [Abstract][Full Text] [Related]
17. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
[TBL] [Abstract][Full Text] [Related]
18. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
19. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
